Test report part 3

File Info : application/pdf, 17 Pages, 5.85MB

Array
(
    [0] => Array
        (
            [url_sha] => 8a244b04908a26cd2a4f199d35d24874d07259f95cfeb32ac7be6edde60a2809
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=7637694
            [href_text] => Test report part 3
            [href_description] => Resvent Medical Technology Co., Ltd. 0005 RXiBreeze PAP System 2A6LY-0005 2A6LY0005 0005
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=7637694
            [http_size] => 6133358
            [file_sha256] => 923eabd32bc651092afb2d7b299755502e53967acc7f56d0289e31efa113d9a5
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 7637694
            [file_sha256] => 
            [applicationId] => 8LA6zkGwAMc+OtDymRYn5A==
            [description] => Test report part 3
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Test Report
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 6133360
            [submissionDate] => 2024-09-05 00:00:00
            [dateAvailable] => 2024-09-05 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2A6LY-0005
            [cleanFccId] => 2A6LY0005
            [exif] => 0
        )

)